US Patent Issued to Cerner Innovation on Oct. 6 for "Macrophage activation syndromes severity prediction" (Kansas Inventor)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,755,819, issued on Oct. 6, was assigned to Cerner Innovation Inc. (Kansas City, Mo.).

"Macrophage activation syndromes severity prediction" was invented by Douglas S. McNair (Leawood, Kan.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Technologies are disclosed for quantitatively predicting whether or not a deterioration in their health status is likely within a future time interval subsequent to computing a prediction. In one embodiment, serial medical data of a particular patient is received from a plurality of inputs. Based on a transformation of the received data, a predicted probability of acute deterioration (PPOD) score is determined. The PPOD sc...